INTRODUCTION
The original stimulus for studying the genetics of foot-and-mouth disease (FMD) virus came from the variability observed with the disease in both virulence and im munogenicity (4) . The initial work was dependent on growing and assaying the virus in mice and, although Subak-Sharpe and his co-workers did some very thorough and careful work on mouse genetics which established a sensitive mouse model (36) , pro gress on the genetics of the virus was slow (37, 28) . More rapid progress began with the advent of reliable tissue culture systems coupled with the use of conditional lethal mutants. Whereas several laboratories were involved in the early work (reviewed in references 2 and 4), only a few persisted and the principal contribution has been made by a succession of workers at Pirbright. Therefore, this is principally a review of their work. There have been three major areas of interest; the first two -mutation and recombination -are important as possible mechanisms by which the virus could change, and the third -genetic analysis -is the application of genetic techniques to the study of genome function.
MUTATION
There is now a general consensus that all RNA viruses have an equally high muta tion rate (10) , but initially it was thought that variable viruses like FMD virus might have a higher mutation rate than other picornaviruses, such as poliovirus, which are apparently more stable (2) .
Rate of mutation
Three different studies involving mutation to resistance to heat inactivation (28) , reversion of individual ts mutations to ts* (23) and mutation to monoclonal an tibody resistance (Xie, Q.-C. and McCahon, D., unpublished results) gave mutation frequencies of between 10 -38 and 10 -56 . These are very similar to the high rates observed for possible single mutations in other RNA viruses. Therefore, a high muta tion rate alone cannot explain the apparent difference in variability between FMD virus and other, more stable, picornaviruses.
Detection of mutation among field isolates
Early work showed that field isolates differed in a variety of biological markers, even isolates from within the same outbreaks (9, 28) . However, such markers were unreliable and their molecular basis was unknown. Consequently, they could not be used in systematic studies on the evolution of the virus in the field. More recently, two biochemical techniques, isoelectric focusing of the virus polypeptides and twodimensional analysis of T, nuclease resistant oligonucleotides of the RNA, have proved to be sensitive and reliable methods for detecting change in this virus. This has had immediate practical application in tracing the source of outbreaks of disease. For example, in each of the four recent European outbreaks (Northern France-UK, 1981; Denmark, 1982; Holland, 1984; Italy, 1984-85 ), the causative virus was shown to be indistinguishable from that of the vaccine being used or produced in that area (14) .
Isoelectric focusing has also been used to study the accumulation of mutations under three different field conditions: disease in fully susceptible animal populations (type O virus in the UK in 1967-68 and in Denmark in 1982), disease in a partially vaccinated animal population (type A virus in Italy, 1984-85) and sequential isolates from carrier cattle and buffalo (types A and SAT 2) (McCahon, D. and Cleary, A.M., unpublished results). In the fully susceptible animals only occasional mutations were observed and they rarely persist (see VP1 mutation in isolates obtained during the Danish outbreak in 1982, Fig. 1 ). No such permanent change was observed in 70 isolates from the much larger UK outbreak of 1967-68. In contrast, in the first 25 isolates obtained from the type A outbreak in Italy, where at least some of the animals were routinely vaccinated, a rapid accumulation of mutations was observed (Fig. 2) . This pattern of accumulation was consistent with what was known about the spread of the disease from epidemiological studies. A similar accumulation of mutations was also observed in sequential isolates obtained from carrier animals but, unlike the other two situations, mixtures of mutant viruses were frequently observed.
Therefore, it seems that the rate of accumulation of mutations in the virus varies depending on the situation, but the factors affecting this are complex. There was no 
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FIG. 1 Evolution within the foot-and-mouth disease outbreak in Denmark, 1982
Electrofocusing of the induced polypeptides of each isolate done as described in ref. 11 except that all growth was in primary bovine thyroid cells. apparent correlation with the type of animal involved, nor with the presence of an tibody. Many of the changes detected were in non-structural polypeptides (see Table I ) which are not involved in inducing a protective response against this disease. 
Location of mutations in the genome
Two types of data show that mutations do not accumulate randomly on the genome, namely, isoelectric focusing studies and sequence information. At least 200 isolates from five serotypes have now been examined by electrofocusing and the general distribution of electrophoretic mutations is very similar for all serotypes. Table I il lustrates this for the three serotypes which have been studied most extensively. Ap proximately 70% of the coding potential of the genome is examined by this technique and mutations are most frequently observed in the three large capsid proteins (VP1, 2 and 3) and the polymerase (p56a), but only rarely in the other polypeptides.
More precise evidence of conserved and variable regions has been obtained by comparison of genome sequences of the evolutionarily distinct European (O and A) serotypes and an African serotype (SAT 2). We (Ortlepp, S.A., King, A.M.Q. and Newman, J.W., unpublished results) have recently sequenced approximately 50% of the SAT 2 genome and compared it with the published sequences for types O and A (6, 8) . Blocks of conserved sequences can be seen in both the 5' and 3' untranslated regions and in the regions encoding the non-structural proteins (p20a, p34, pl9, VPg, p20b and p56a), where 80-85% of the nucleotide sequence is conserved. At the amino acid level, the degree of conservation in VPg and p56a is very striking (90-95%). Therefore, although the mutation rate may be high, the mutations only accumulate in regions where they are tolerated -which is principally in the larger capsid proteins.
RECOMBINATION
Recombination offers the opportunity for the exchange of large segments of genetic information and therefore has the potential to produce large shifts in the biological behaviour of the virus. Recombination in DNA is well-known, but for many years the only evidence of RNA recombination was limited to picornaviruses and was based on biological evidence (7) . Principally through the studies on FMD virus, there is now extensive biochemical evidence on the existence and potential of this mechanism to produce change in picornaviruses.
Construction of a genetic map
Early work by Pringle and his collaborators (29, 31) , using a variety of biological markers, showed that recombination could occur between different strains of the virus. However, it was not until the advent of conditional lethal mutants (principally temperature-sensitive, ts) that a more systematic analysis became possible. Recombina tion frequencies were very low (at best 0.1% to 0.5 % of the virus yield) and very variable but, after a great deal of persistence by a succession of workers (30, 22, 18, 27) , a genetic map was constructed (Fig. 3) . Subsequently, a variety of ts mutations in the map were shown to co-vary with an electrophoretic mutation detectable by electrofocusing (11, 13, 23) . Thus, the physical location of these te mutations could be identified; this showed that the genetic map could be aligned with the biochemical map (13, 5) and that it represented most of the coding region of the virus genome (Fig. 3) .
Biochemical evidence of RNA recombination
The low frequency of recombination made the isolation of recombinants for biochemical examination very difficult. A major advance was the development of an infectious centre test (24) in which cells were infected with two mutants and then assayed on uninfected cells at the restrictive condition. Under these conditions, even if a suitable recombination event occurred only once in the multiply-infected cells, it might be expected to generate a plaque. In fact, recombination was shown to oc cur in up to 28% of cells infected with two mutants of the same strain. Using this method, recombinants were isolated between a range of biochemically distinguishable viruses. The initial experiments involved mutants of the same strain, each with elec trophoretic mutations in two proteins, and recombinants were isolated which possessed an electrophoretic mutation from each parent (12) . More conclusive evidence was provided by recombinants obtained between ts mutants of two biochemically distinguishable type O subtypes (15) . These viruses could be distinguished in all their major polypeptides by electrofocusing and in approximately 25 of the T ,-ribonuclease resistant oligonucleotides obtained from their RNA. Two different types of recombinant were demonstrated. One type had a cross-over between the capsid proteins and p34 (Rec 1), the other type a cross-over between p34 and p56a (Ree 2) (see Fig. 4 ).
Limitations on RNA recombination
Using the infectious centre method, a wide range of recombinants was isolated from a variety of crosses between mutants of the two type O subtypes (16) . Forty presumptive recombinants were analysed by electrofocusing of their proteins and twodimensional analysis of their oligonucleotides, and 38 were found to be recombinant. Seventeen different patterns were observed, reflecting at least 12 cross-over points on the genome (Fig. 5) . Double cross-overs were seen in 3 out of 38 recombinants (recombinants 13, 15 and 17 of Fig. 5 ), which is much higher than expected and sug gests that one cross-over event predisposes to another. The locations of the various cross-overs were defined by determining the genome location of each unique oligonucleotide of each parent. This was done by sequencing the various oligonucleotides and then identifying their location on the available genome sequence for a type O virus (8) . This analysis showed that the cross-overs were scattered throughout the genome. Therefore, recombination can probably occur at many sites, suggesting that it is a general rather than a site-specific phenomenon.
The possible limitations when the parental viruses were not so closely related were explored (26) by using the same basic approach to obtain and examine recombinants between European subtypes O and A and representatives of the evolutionary distant African serotype (SAT 2). Some of these are illustrated in Fig. 6 . The frequency of isolation of viable recombinants was much less with the more distantly related pairs -285 (O X SAT and A X SAT) but the fact that they could be obtained demonstrated that they could occur, given the right opportunity and selection conditions. Interestingly, nearly all such recombinants had recombinant proteins of unique electrophoretic mobi lity which could well produce a new phenotype.
Sequence requirements for RNA recombination
The cross-over points of five of the O X SAT recombinants and the appropriate regions of their parental viruses have been sequenced. Two of these are illustrated in Fig. 7 . Since the two parental viruses are considered to be evolutionary distant, the cross-over sites of these recombinants should provide the minimum sequence requi red for recombination to occur. In fact, there appears to be little requirement for perfect homology at the cross-over site (the number varied from 2 to 32 nucleotides) and there is no apparent consensus sequence that is close to the cross-over site. All the cross-overs were in a region of high homology (70-80%), which may indicate that an overall degree of homology is necessary.
Therefore, in conclusion, RNA recombination can clearly occur, probably all over the genome, and even between the most distantly related viruses. Not surprisingly, the probability of a viable recombinant appears to decrease with increasing evolutio nary distance. However, given the opportunity, recombination would appear to have the potential to be an important force in the evolution of the virus. Clear biochemi cal evidence of RNA recombination has also been obtained in poliovirus (1) and murine Coronavirus (17).
GENETIC ANALYSIS
The genetic studies on the virus have also contributed to our knowledge of the function of the genome in two important areas, RNA replication and antigenic structure.
RNA replication
Several workers have isolated the RNA polymerase from infected cells in varying degrees of purity and demonstrated that the principal component is p56a (19, 20) . Two ts mutants were found to have electrophoretic mutations in their p56a which co-varied with their ts mutation, so demonstrating that their ts mutations were in p56a. The isolated p56a from these two mutants was shown to be temperature-sensitive in polymerase activity in vitro and so provided independent proof that p56a was the viral polymerase (21) . A variety of such mutants are now available and could be used to analyse further the function of this protein.
Genetic studies provided the first evidence that the other major non-structural protein, p34, is also involved in RNA replication. This was based on the demonstra tion that resistance to the antiviral drug, guanidine, which specifically inhibits virus RNA replication, is determined by p34. The initial evidence was the finding from electrofocusing analyses (34) that gr mutants frequently had an electrophoretically altered p34 (Fig. 8) . This was confirmed by other techniques, including recombina tion analysis, and ultimately by sequencing studies to show that mutations to guani dine resistance occur at the 3' end of p34 (35) . Many studies have shown an effect of guanidine on Picornavirus RNA replication (3) but purified preparations of soluble polymerase which contain principally p56a, not p34, are insensitive to the drug. Therefore, p34 must have a function that is essential for continued RNA synthesis in vivo even though it is not, itself, the polymerase. Since p34 is a membrane-bound protein and since some of the effects of guanidine resemble those of non-ionic detergents on viral RNA synthesis in cell extracts, we have suggested that p34 is im portant in maintaining the association of the replication complex with the smooth membranes of the cell.
Antigenic structure
Genetic analysis of the antigenic structure of the virus recently became possible with the advent of highly specific and effective neutralising monoclonal antibodies. Using five such antibodies, a selection of about 30 different mutants were isolated. By ELISA and cross-neutralisation tests, three non-overlapping antigenic sites were found (Fig. 9) . Two of the sites were shown to be conformation-dependent in that they cannot be detected on partially disrupted virus. These appear to be completely novel sites not previously identified. Sequencing studies are in progress to define their location on the virus particle. The third site, B2/D9, appears to be a sequential site located within the 140 to 160 amino acid segment of VP1. Therefore, this site cor responds to the well-known antigenic site on VP1 defined by biochemical studies (5).
CONCLUSIONS
Extensive fundamental work has been done on the genetics of this virus but there are still many interesting questions unanswered. Recombination has been established as a valid mechanism of change but we have little idea of the mechanism involved. Like all other RNA viruses, foot-and-mouth disease virus has a high mutation rate but mutations do not accumulate randomly in the genome. The sequence of some areas is highly conserved and must reflect the function of the RNA or the encoded protein in that region, yet we know little about those functions. Conversely, muta tions are tolerated in much of the capsid coding region, which could explain the an tigenic variability of the virus. However, even within the capsid region one would expect some conservation to preserve vital functions such as receptor sites which are probably common to all FMD viruses. The analysis of genome functions using ran domly isolated mutants has been slow and often unrewarding but some helpful in formation has been obtained, particularly on RNA replication and the antigenic structure of the virus capsid. Recombinant DNA technology provides the opportuni ty to tackle many of these areas in a more precise way than could ever be possible by conventional genetics. That makes the future of FMD virus genetics both interesting and exciting. 
